Payer policies can also influence pediatric research, particularly in the area of pharmaceutical and medical device development. Policies that provide coverage for new treatments and technologies can encourage innovation and investment in pediatric healthcare. Conversely, restrictive policies may limit access to new therapies and hinder clinical research efforts.
